168 related articles for article (PubMed ID: 35389467)
1. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis.
Arora R; Goel R; Meher R
JAMA Ophthalmol; 2022 May; 140(5):548. PubMed ID: 35389467
[No Abstract] [Full Text] [Related]
2. Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis-Reply.
Date PS; Choksi T; Ingole AB
JAMA Ophthalmol; 2022 May; 140(5):548-549. PubMed ID: 35389457
[No Abstract] [Full Text] [Related]
3. Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis.
Murthy R; Bagchi A; Gote Y; Desai S
Indian J Ophthalmol; 2022 Jan; 70(1):302-305. PubMed ID: 34937263
[TBL] [Abstract][Full Text] [Related]
4. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
[TBL] [Abstract][Full Text] [Related]
5. Rhino-orbito-cerebral mucormycosis.
Raymundo IT; Araújo BG; Costa Cde C; Tavares JP; Lima CG; Nascimento LA
Braz J Otorhinolaryngol; 2009; 75(4):619. PubMed ID: 19784435
[No Abstract] [Full Text] [Related]
6. Fungal Endophthalmitis in a Case of Rhino-Orbital-Cerebral Mucormycosis Treated with 0.02% Intravitreal Liposomal Amphotericin B Injection: A Case Report.
Jung S; Kim MS
Korean J Ophthalmol; 2023 Oct; 37(5):434-436. PubMed ID: 37699555
[No Abstract] [Full Text] [Related]
7. Rhino-Orbital-Cerebral Mucormycosis-Another Deadly Complication of COVID-19 Infection.
Tooley AA; Bradley EA; Woog JJ
JAMA Ophthalmol; 2022 Jan; 140(1):73-74. PubMed ID: 34882174
[No Abstract] [Full Text] [Related]
8. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
[TBL] [Abstract][Full Text] [Related]
9. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
10. Rhino-orbital-cerebral mucormycosis in COVID-19 patients - Taming the black evil with pharmacological weapons.
Kaur K; Gurnani B
Indian J Pharmacol; 2021; 53(5):417-419. PubMed ID: 34854414
[No Abstract] [Full Text] [Related]
11. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
12. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
[TBL] [Abstract][Full Text] [Related]
13. Intraconal amphotericin B for the treatment of rhino-orbital mucormycosis.
Luna JD; Ponssa XS; Rodríguez SD; Luna NC; Juárez CP
Ophthalmic Surg Lasers; 1996 Aug; 27(8):706-8. PubMed ID: 8858637
[TBL] [Abstract][Full Text] [Related]
14. The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.
Naik MN; Rath S
Semin Ophthalmol; 2022 Apr; 37(3):279-283. PubMed ID: 34260342
[TBL] [Abstract][Full Text] [Related]
15. Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience.
Ramamurthy LB; Bhandari R; Kanakpur S; Thejaswini P
Indian J Ophthalmol; 2022 Mar; 70(3):1019-1024. PubMed ID: 35225564
[TBL] [Abstract][Full Text] [Related]
16. [Rhino-orbito-cerebral mucormycosis].
Trabelsi S; Marrakchi J; Aloui D; Lahiani R; Sellami A; Ben Salah M; Ferjaoui M; Khaled S
Tunis Med; 2013 Feb; 91(2):164-5. PubMed ID: 23526289
[No Abstract] [Full Text] [Related]
17. Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review.
Sharifi A; Akbari Z; Shafie'ei M; Nasiri N; Sharifi M; Shafiei M; Zand A
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):425-432. PubMed ID: 35943425
[TBL] [Abstract][Full Text] [Related]
18. Retrobulbar Injection of Amphotericin B for Orbital Mucormycosis.
Hirabayashi KE; Kalin-Hajdu E; Brodie FL; Kersten RC; Russell MS; Vagefi MR
Ophthalmic Plast Reconstr Surg; 2017; 33(4):e94-e97. PubMed ID: 27768642
[TBL] [Abstract][Full Text] [Related]
19. Rise of the phoenix: Mucormycosis in COVID-19 times.
Ravani SA; Agrawal GA; Leuva PA; Modi PH; Amin KD
Indian J Ophthalmol; 2021 Jun; 69(6):1563-1568. PubMed ID: 34011742
[TBL] [Abstract][Full Text] [Related]
20. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
